Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;42(7):1555-1562.
doi: 10.1002/nau.25240. Epub 2023 Jul 4.

Ketamine uropathy: Clinical experience in a high prevalence center

George Sturgess  1   2 , Ian Beckley  1   2 , Robin Shepherd  1   2 , Alison Downey  1   2
Affiliations

Ketamine uropathy: Clinical experience in a high prevalence center

George Sturgess et al. Neurourol Urodyn. 2023 Sep.

Abstract

Objectives: Ketamine uropathy causes inflammatory changes to the urothelium, manifesting as significant lower urinary tract symptoms, small bladder capacity, and pelvic pain. Upper tract involvement and hydronephrosis can occur. Data from UK centers are limited, and no formal treatment guidelines exist.

Patients and methods: All patients with ketamine uropathy presenting to our unit over an 11-year period were identified through operative and clinic lists, emergency presentations, and a prospectively collected local database. Demographic data, biochemical findings, imaging techniques, and both medical and surgical management were recorded.

Results: A total of 81 patients with ketamine uropathy were identified from 2011 to 2022; however, a large proportion presented from 2018 onwards. The average age at presentation was 26 years (interquartile range [IQR]: 27-34), 72.8% were male, and average follow-up time was 34 months (IQR: 8-46). Therapeutic interventions included anticholinergic medication, cystodistension, and intravesical sodium hyaluronate. Hydronephrosis was present in 20 (24.7%) patients and nephrostomy insertion was required in six. One patient underwent bladder augmentation surgery. Serum gamma-glutamyl transferase and length of follow-up were significantly higher in patients with hydronephrosis. Adherence to follow-up was poor.

Conclusions: We present a large cohort of patients with ketamine uropathy from a small town in the UK which is unusual. The incidence appears to be rising, in-keeping with increasing recreational ketamine use and should be of concern to urologists. Abstinence is a key aspect of management, and a multi-disciplinary approach works best particularly as many patients are lost to follow-up. The development of formal guidance would be helpful.

Keywords: drugs and addiction; gamma-glutamyl transferase (GGT); hydronephrosis; ketamine bladder; ketamine uropathy.

PubMed Disclaimer

References

REFERENCES

    1. Shahani R, Streutker C, Dickson B, Stewart RJ. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology. 2007;69(5):810-812.
    1. Chu PS, Kwok SC, Lam KM, et al. Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J. 2007;13(4):311-313.
    1. Chu PSK, Ma WK, Wong SCW, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008;102(11):1616-1622.
    1. Huang PW, Wu ST, Tsao CW, et al. Is urodynamic study a good witness to the progression of ketamine-associated cystitis? Low Urin Tract Symptoms. 2014;6(2):98-102.
    1. Yee CH, Teoh JYC, Lai PT, et al. The risk of upper urinary tract involvement in patients with ketamine-associated uropathy. Int Neurourol J. 2017;21(2):128-132.